We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1kjl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1kjl.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1kjl.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1kjl| PDB=1kjl | SCENE= }}
{{STRUCTURE_1kjl| PDB=1kjl | SCENE= }}
-
'''High Resolution X-Ray Structure of Human Galectin-3 in complex with LacNAc'''
+
===High Resolution X-Ray Structure of Human Galectin-3 in complex with LacNAc===
-
==Overview==
+
<!--
-
The high-resolution X-ray crystal structures of the carbohydrate recognition domain of human galectin-3 were solved in complex with N-acetyllactosamine (LacNAc) and the high-affinity inhibitor, methyl 2-acetamido-2-deoxy-4-O-(3-deoxy-3-[4-methoxy-2,3,5,6-tetrafluorobenzamido ]-beta-D-galactopyranose)-beta-D-glucopyranoside, to gain insight into the basis for the affinity-enhancing effect of the 4-methoxy-2,3,5,6-tetrafluorobenzamido moiety. The structures show that the side chain of Arg144 stacks against the aromatic moiety of the inhibitor, an interaction made possible by a reorientation of the side chain relative to that seen in the LacNAc complex. Based on these structures, synthesis of second generation LacNAc derivatives carrying aromatic amides at 3'-C, followed by screening with a novel fluorescence polarization assay, has led to the identification of inhibitors with further enhanced affinity for galectin-3 (K(d) &gt; or = 320 nM). The thermodynamic parameters describing the binding of the galectin-3 C-terminal to selected inhibitors were determined by isothermal titration calorimetry and showed that the affinity enhancements were due to favorable enthalpic contributions. These enhancements could be rationalized by the combined effects of the inhibitor aromatic structure on a cation-Pi interaction and of direct interactions between the aromatic substituents and the protein. The results demonstrate that protein-ligand interactions can be significantly enhanced by the fine-tuning of arginine-arene interactions.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15701008}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15701008 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15701008}}
==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Sorme, P.]]
[[Category: Sorme, P.]]
[[Category: Lacnac complex]]
[[Category: Lacnac complex]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 22:49:13 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 2 10:26:07 2008''

Revision as of 07:26, 2 July 2008

Image:1kjl.png

Template:STRUCTURE 1kjl

High Resolution X-Ray Structure of Human Galectin-3 in complex with LacNAc

Template:ABSTRACT PUBMED 15701008

About this Structure

1KJL is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction., Sorme P, Arnoux P, Kahl-Knutsson B, Leffler H, Rini JM, Nilsson UJ, J Am Chem Soc. 2005 Feb 16;127(6):1737-43. PMID:15701008

Page seeded by OCA on Wed Jul 2 10:26:07 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1kjl"
Personal tools